Author + information
- Anselm K. Gitt,
- Matthias Hochadel,
- Francois Schiele,
- Wojtek Wojakowski,
- Michal Tendera,
- Ralf Zahn and
- Uwe Zeymer
Patients with NSTE-ACS often have diabetes (Diab) and / or renal failure (RF). It is unclear if RF and Diab are independent predictors of hospital mortality in NSTE-ACS.
In 2006 to 2008, consecutive patients with ACS were enrolled into the EHS-ACS-Registry to document treatment and hospital outcome. We examined the impact of Diab and RF (GFR < 60ml/kg/min) on hospital outcome in patients with NSTE-ACS.
Of all ACS, 12,833 presented with NSTE-ACS. Patients with RF were older and more often had concomitant diseases independent of the presence of Diab. In multivariate analysis, RF but not Diab predicted hospital mortality.
In patients with NSTE-ACS, RF outplayed Diab in the prediction of hospital mortality in NSTE-ACS and might be more important in risk stratification than Diab.
|Female Gender (%)||34.6||42.8||31.3||35.2|
|Prior MI (%)||26.0||33.9||42.0||52.0|
|Prior PCI (%)||15.2||21.4||25.9||30.7|
|Prior CABG (%)||5.4||8.5||11.8||15.3|
|Prior Stroke (%)||5.2||8.1||9.6||13.0|
|Killip 4 (%)||0.9||1.3||1.3||3.4|
|Multivessel disease (%)||64.1||72.6||75.3||85.0|
Poster Sessions, Expo North
Sunday, March 10, 2013, 3:45 p.m.-4:30 p.m.
Session Title: Comorbidity and ACS: COPD, Renal Dysfunction, Diabetes
Abstract Category: 1. Acute Coronary Syndromes: Clinical
Presentation Number: 1257-191
- 2013 American College of Cardiology Foundation